According to Inozyme Pharma's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -$62.58 Million USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -$96.47 Million | 54.17% |
2023 | -$62.58 Million | -8.89% |
2022 | -$68.68 Million | 21.24% |
2021 | -$56.65 Million | -0.69% |
2020 | -$57.05 Million | 174.17% |
2019 | -$20.81 Million |